imiquimod has been researched along with Animal Mammary Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, Y; Chen, G; Chen, J; Chen, Q; Dong, Z; Du, Y; Jin, Q; Liang, C; Liu, Z; Tao, H; Wang, C; Wu, D; Xiao, Z; Xu, J | 1 |
| Hill, B; Jing, D; Lam, KS; Li, JJ; Li, Y; Sun, Y; Wang, L; Yang, F; Zhang, L | 1 |
2 other study(ies) available for imiquimod and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses.
Topics: Adjuvants, Immunologic; Alginates; Animals; Antibodies, Neoplasm; Antibodies, Neutralizing; B7-H1 Antigen; Cell Line, Tumor; Colonic Neoplasms; Combined Modality Therapy; Dendritic Cells; Doxorubicin; Female; Gels; Humans; Imiquimod; Immunotherapy; Injections, Intralesional; Lymphocytes, Tumor-Infiltrating; Macrophages; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oxaliplatin; Tumor Microenvironment | 2020 |
Unique Photochemo-Immuno-Nanoplatform against Orthotopic Xenograft Oral Cancer and Metastatic Syngeneic Breast Cancer.
Topics: Animals; Cell Line, Tumor; Drug Carriers; Female; Heterografts; Humans; Imiquimod; Immunologic Factors; Isografts; Mammary Neoplasms, Animal; Mice; Mouth Neoplasms; Nanoparticles; Photochemotherapy; Xenograft Model Antitumor Assays | 2018 |